These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12678567)

  • 1. Outpatient therapy for febrile neutropenia: clinical and economic implications.
    de Lalla F
    Pharmacoeconomics; 2003; 21(6):397-413. PubMed ID: 12678567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.
    Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Cumsille MA; O'Ryan ML; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    J Clin Oncol; 2004 Sep; 22(18):3784-9. PubMed ID: 15365075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer.
    Teuffel O; Amir E; Alibhai SM; Beyene J; Sung L
    Pediatrics; 2011 Feb; 127(2):e279-86. PubMed ID: 21220399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of outpatient treatment of febrile neutropenia on the risk threshold for the use of CSF in patients with cancer treated with chemotherapy.
    Cosler LE; Sivasubramaniam V; Agboola O; Crawford J; Dale D; Lyman GH
    Value Health; 2005; 8(1):47-52. PubMed ID: 15841893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in management of low-risk febrile neutropenia.
    Teuffel O; Sung L
    Curr Opin Pediatr; 2012 Feb; 24(1):40-5. PubMed ID: 22037219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia.
    Elting LS; Lu C; Escalante CP; Giordano SH; Trent JC; Cooksley C; Avritscher EB; Shih YC; Ensor J; Bekele BN; Gralla RJ; Talcott JA; Rolston K
    J Clin Oncol; 2008 Feb; 26(4):606-11. PubMed ID: 18235119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The outpatient management of febrile neutropenia in cancer patients.
    Freifeld AG; Pizzo PA
    Oncology (Williston Park); 1996 Apr; 10(4):599-606, 611-2; discussion 615-6. PubMed ID: 8723296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost analysis of febrile neutropenia management in Australia: ambulatory v. in-hospital treatment.
    Lingaratnam S; Worth LJ; Slavin MA; Bennett CA; Kirsa SW; Seymour JF; Dalton A; Koczwara B; Prince HM; O'Reilly M; Mileshkin L; Szer J; Thursky KA
    Aust Health Rev; 2011 Nov; 35(4):491-500. PubMed ID: 22126955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children.
    Raisch DW; Holdsworth MT; Winter SS; Hutter JJ; Graham ML
    Value Health; 2003; 6(2):158-66. PubMed ID: 12641866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic implications of step-down outpatient management for fever and neutropenia episodes in pediatric cancer patients: a cost minimization analysis.
    Avilés-Robles MJ; Reyes-López A
    BMC Health Serv Res; 2024 Aug; 24(1):981. PubMed ID: 39182090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.
    Teuffel O; Amir E; Alibhai S; Beyene J; Sung L
    Br J Cancer; 2011 Apr; 104(9):1377-83. PubMed ID: 21468048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and costs of treating neutropenic fever in an outpatient setting.
    Del Prete SA; Ryan SP; Jacobson JS; Erichson RB; Weinstein PL; Grann VR
    Conn Med; 1999 Dec; 63(12):713-7. PubMed ID: 10659471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An organizational and economic approach in France to the ambulatory treatment of febrile neutropenia].
    Turlure P; Durand-Zaleski I
    Presse Med; 2004 Mar; 33(5):338-42. PubMed ID: 15041886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and cost benefit of an ambulatory program for patients with low-risk neutropenic fever at an Australian centre.
    Teh BW; Brown C; Joyce T; Worth LJ; Slavin MA; Thursky KA
    Support Care Cancer; 2018 Mar; 26(3):997-1003. PubMed ID: 29018966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving concepts of management of febrile neutropenia in children with cancer.
    Orudjev E; Lange BJ
    Med Pediatr Oncol; 2002 Aug; 39(2):77-85. PubMed ID: 12116054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe and effective outpatient treatment of adults with chemotherapy-induced neutropenic fever.
    Moores KG
    Am J Health Syst Pharm; 2007 Apr; 64(7):717-22. PubMed ID: 17384356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
    Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.